GT Biopharma Inc (GTBP)
3.05
+0.08
(+2.69%)
USD |
NASDAQ |
Nov 04, 16:00
2.95
-0.10
(-3.28%)
After-Hours: 20:00
GT Biopharma Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2015 | -0.1937 |
| March 31, 2015 | -0.0755 |
| December 31, 2014 | -0.1142 |
| September 30, 2014 | -0.2801 |
| June 30, 2014 | -0.4144 |
| March 31, 2014 | -0.4159 |
| December 31, 2013 | -0.4187 |
| September 30, 2013 | -0.3895 |
| June 30, 2013 | -0.3926 |
| March 31, 2013 | -0.3693 |
| December 31, 2012 | -0.301 |
| September 30, 2012 | -0.4386 |
| June 30, 2012 | -0.3434 |
| March 31, 2012 | -0.418 |
| December 31, 2011 | -0.404 |
| September 30, 2011 | -0.0404 |
| June 30, 2011 | -0.3759 |
| March 31, 2011 | -0.2901 |
| December 31, 2010 | -0.3957 |
| September 30, 2010 | -0.4127 |
| June 30, 2010 | -0.4251 |
| March 31, 2010 | -0.3657 |
| December 31, 2009 | -0.4147 |
| September 30, 2009 | -0.4999 |
| June 30, 2009 | -0.508 |
| Date | Value |
|---|---|
| March 31, 2009 | -0.5441 |
| December 31, 2008 | -0.5837 |
| September 30, 2008 | -0.6013 |
| June 30, 2008 | -0.3881 |
| March 31, 2008 | -4.128 |
| December 31, 2007 | 0.00 |
| September 30, 2007 | 1.421 |
| June 30, 2007 | 14.31 |
| March 31, 2007 | -0.2587 |
| December 31, 2006 | -5.537 |
| September 30, 2006 | 2.334 |
| June 30, 2006 | 1.918 |
| March 31, 2006 | 1.565 |
| December 31, 2005 | 1.043 |
| September 30, 2005 | 0.00 |
| June 30, 2005 | 0.00 |
| March 31, 2005 | 0.0278 |
| December 31, 2004 | 0.2346 |
| September 30, 2004 | -5.860 |
| June 30, 2004 | -5.789 |
| March 31, 2004 | 0.3237 |
| December 31, 2003 | 0.1839 |
| September 30, 2003 | 0.1772 |
| June 30, 2003 | 0.1961 |
| March 31, 2003 | 0.149 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | -1.128 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.0461 |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 9.267M |
| Total Liabilities (Quarterly) | 3.759M |
| Shareholders Equity (Quarterly) | 5.508M |